208 related articles for article (PubMed ID: 9554499)
1. Serum kynurenine-to-tryptophan ratio increases with progressive disease in HIV-infected patients.
Huengsberg M; Winer JB; Gompels M; Round R; Ross J; Shahmanesh M
Clin Chem; 1998 Apr; 44(4):858-62. PubMed ID: 9554499
[TBL] [Abstract][Full Text] [Related]
2. The kynurenine pathway activities in a sub-Saharan HIV/AIDS population.
Bipath P; Levay PF; Viljoen M
BMC Infect Dis; 2015 Aug; 15():346. PubMed ID: 26285873
[TBL] [Abstract][Full Text] [Related]
3. Effective antiretroviral therapy reduces degradation of tryptophan in patients with HIV-1 infection.
Zangerle R; Widner B; Quirchmair G; Neurauter G; Sarcletti M; Fuchs D
Clin Immunol; 2002 Sep; 104(3):242-7. PubMed ID: 12217334
[TBL] [Abstract][Full Text] [Related]
4. Decreased serum tryptophan in patients with HIV-1 infection correlates with increased serum neopterin and with neurologic/psychiatric symptoms.
Fuchs D; Möller AA; Reibnegger G; Stöckle E; Werner ER; Wachter H
J Acquir Immune Defic Syndr (1988); 1990; 3(9):873-6. PubMed ID: 2166783
[TBL] [Abstract][Full Text] [Related]
5. The kynurenine pathway of tryptophan catabolism, CD4+ T-cell recovery, and mortality among HIV-infected Ugandans initiating antiretroviral therapy.
Byakwaga H; Boum Y; Huang Y; Muzoora C; Kembabazi A; Weiser SD; Bennett J; Cao H; Haberer JE; Deeks SG; Bangsberg DR; McCune JM; Martin JN; Hunt PW
J Infect Dis; 2014 Aug; 210(3):383-91. PubMed ID: 24585899
[TBL] [Abstract][Full Text] [Related]
6. Inter-relationships between quinolinic acid, neuroactive kynurenines, neopterin and beta 2-microglobulin in cerebrospinal fluid and serum of HIV-1-infected patients.
Heyes MP; Brew BJ; Saito K; Quearry BJ; Price RW; Lee K; Bhalla RB; Der M; Markey SP
J Neuroimmunol; 1992 Sep; 40(1):71-80. PubMed ID: 1387655
[TBL] [Abstract][Full Text] [Related]
7. The Kynurenine Pathway of Tryptophan Catabolism and AIDS-Associated Kaposi Sarcoma in Africa.
Byakwaga H; Hunt PW; Laker-Oketta M; Glidden DV; Huang Y; Bwana BM; Mocello AR; Bennett J; Walusansa V; Dollard SC; Bangsberg DR; Mbidde EK; Martin JN
J Acquir Immune Defic Syndr; 2015 Nov; 70(3):296-303. PubMed ID: 26181812
[TBL] [Abstract][Full Text] [Related]
8. Serum tryptophan and kynurenine concentrations as parameters for indoleamine 2,3-dioxygenase activity in patients with endometrial, ovarian, and vulvar cancer.
de Jong RA; Nijman HW; Boezen HM; Volmer M; Ten Hoor KA; Krijnen J; van der Zee AG; Hollema H; Kema IP
Int J Gynecol Cancer; 2011 Oct; 21(7):1320-7. PubMed ID: 21720257
[TBL] [Abstract][Full Text] [Related]
9. Tryptophan catabolism increases in breast cancer patients compared to healthy controls without affecting the cancer outcome or response to chemotherapy.
Onesti CE; Boemer F; Josse C; Leduc S; Bours V; Jerusalem G
J Transl Med; 2019 Jul; 17(1):239. PubMed ID: 31337401
[TBL] [Abstract][Full Text] [Related]
10. Peripheral kynurenine/tryptophan ratio is not a reliable marker of systemic indoleamine 2,3-dioxygenase: A lesson drawn from patients on hemodialysis.
Chen Y; Xie Z; Xiao C; Zhang M; Li Z; Xie J; Zhang Y; Zhao X; Zeng P; Mo L; Liang X; Shi W
Oncotarget; 2017 Apr; 8(15):25261-25269. PubMed ID: 28445957
[TBL] [Abstract][Full Text] [Related]
11. Parallel decrease in neurotoxin quinolinic acid and soluble tumor necrosis factor receptor p75 in serum during highly active antiretroviral therapy of HIV type 1 disease.
Look MP; Altfeld M; Kreuzer KA; Riezler R; Stabler SP; Allen RH; Sauerbruch T; Rockstroh JK
AIDS Res Hum Retroviruses; 2000 Sep; 16(13):1215-21. PubMed ID: 10957719
[TBL] [Abstract][Full Text] [Related]
12. Reversal of the Kynurenine pathway of tryptophan catabolism may improve depression in ART-treated HIV-infected Ugandans.
Martinez P; Tsai AC; Muzoora C; Kembabazi A; Weiser SD; Huang Y; Haberer JE; Martin JN; Bangsberg DR; Hunt PW
J Acquir Immune Defic Syndr; 2014 Apr; 65(4):456-62. PubMed ID: 24220289
[TBL] [Abstract][Full Text] [Related]
13. Implications of interferon-induced tryptophan catabolism in cancer, auto-immune diseases and AIDS.
Brown RR; Ozaki Y; Datta SP; Borden EC; Sondel PM; Malone DG
Adv Exp Med Biol; 1991; 294():425-35. PubMed ID: 1722946
[TBL] [Abstract][Full Text] [Related]
14. Plasma Tryptophan-Kynurenine Metabolites Are Altered in Human Immunodeficiency Virus Infection and Associated With Progression of Carotid Artery Atherosclerosis.
Qi Q; Hua S; Clish CB; Scott JM; Hanna DB; Wang T; Haberlen SA; Shah SJ; Glesby MJ; Lazar JM; Burk RD; Hodis HN; Landay AL; Post WS; Anastos K; Kaplan RC
Clin Infect Dis; 2018 Jul; 67(2):235-242. PubMed ID: 29415228
[TBL] [Abstract][Full Text] [Related]
15. Clinical Relevance of Kynurenine Pathway in HIV/AIDS: An Immune Checkpoint at the Crossroads of Metabolism and Inflammation.
Routy JP; Mehraj V; Vyboh K; Cao W; Kema I; Jenabian MA
AIDS Rev; 2015; 17(2):96-106. PubMed ID: 26035167
[TBL] [Abstract][Full Text] [Related]
16. Increased serum kynurenine/tryptophan ratio correlates with disease progression in lung cancer.
Suzuki Y; Suda T; Furuhashi K; Suzuki M; Fujie M; Hahimoto D; Nakamura Y; Inui N; Nakamura H; Chida K
Lung Cancer; 2010 Mar; 67(3):361-5. PubMed ID: 19487045
[TBL] [Abstract][Full Text] [Related]
17. Host genetic predictors of the kynurenine pathway of tryptophan catabolism among treated HIV-infected Ugandans.
Lee SA; Mefford JA; Huang Y; Witte JS; Martin JN; Haas DW; Mclaren PJ; Mushiroda T; Kubo M; Byakwaga H; Hunt PW; Kroetz DL
AIDS; 2016 Jul; 30(11):1807-15. PubMed ID: 27088321
[TBL] [Abstract][Full Text] [Related]
18. Tryptophan metabolism in chronic inflammatory lung disease.
Meyer KC; Arend RA; Kalayoglu MV; Rosenthal NS; Byrne GI; Brown RR
J Lab Clin Med; 1995 Dec; 126(6):530-40. PubMed ID: 7490512
[TBL] [Abstract][Full Text] [Related]
19. Effective antiretroviral therapy reduces degradation of tryptophan in patients with HIV-1 infection.
Neurauter G; Zangerle R; Widner B; Quirchmair G; Sarcletti M; Fuchs D
Adv Exp Med Biol; 2003; 527():317-23. PubMed ID: 15206745
[TBL] [Abstract][Full Text] [Related]
20. Tryptophan degradation in patients infected by human immunodeficiency virus.
Werner ER; Fuchs D; Hausen A; Jaeger H; Reibnegger G; Werner-Felmayer G; Dierich MP; Wachter H
Biol Chem Hoppe Seyler; 1988 May; 369(5):337-40. PubMed ID: 3166737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
